VIP 10mg

VIP (Vasoactive Intestinal Peptide) research focuses on this widespread 28-amino acid neuropeptide’s diverse roles as a neurotransmitter, hormone, and neuromodulator, particularly its potent vasodilation, smooth muscle relaxation (lungs, gut), immune regulation, and potential as a therapeutic for inflammatory diseases (arthritis, sepsis), respiratory conditions (asthma, COPD), and neurodegenerative disorders (Alzheimer’s, Parkinson’s), exploring its mechanism in G-protein coupled receptors (GPCRs) and developing targeted delivery systems like inhaled agonists.

Key Research Areas:

• Physiological Functions: Understanding how VIP controls blood flow (vasodilation), gut secretion, hormone release (pancreas), heart function, and circadian rhythms.
• Immunomodulation: Investigating its anti-inflammatory effects, such as suppressing pro-inflammatory cytokines (TNF-α, IL-6) and promoting anti-inflammatory ones (IL-10), crucial for wound healing and autoimmune conditions.
• Neurological Disorders: Exploring its neuroprotective role against inflammation in diseases like Alzheimer’s, Parkinson’s, and Autism Spectrum Disorder (ASD).
• Respiratory Therapeutics: Developing VIP agonists for asthma, COPD, and cystic fibrosis, targeting its bronchodilatory and anti-inflammatory properties.
• Cancer: Studying VIP’s involvement in carcinogenesis and its potential as a therapeutic target.
• Therapeutic Development: Creating stabilized, targeted VIP analogs (e.g., inhaled) and understanding its receptor signaling (VIPR1, VIPR2) to develop new drugs for inflammation, sepsis, and CNS disorders. 

How it Works (Mechanism):

• VIP binds to G-protein coupled receptors (VIPR1, VIPR2), activating intracellular signaling pathways (adenylyl cyclase, phospholipase C).
• It triggers changes in cyclic AMP (cAMP) and cGMP levels, leading to broad effects like smooth muscle relaxation and cytokine modulation.